Dawaa Reference

chronic

Neoplasm of Uncertain Behaviour of the Ear

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class HD25.02 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Vestibular Schwannoma - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK562312/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

A growth that has not yet been classified as benign or malignant needs biopsy and specialist assessment before any treatment decision; the GP's role is referral. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

A growth that has not yet been classified as benign or malignant needs biopsy and specialist assessment before any treatment decision; the GP's role is referral.

Cautions
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Rapid change in size, or bleeding or ulceration pending histology.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.